Class IIOngoingD-0803-2026
Drug recall · September 2, 2026
Acthar Gel recall
Why: Presence of particulate matter: glass and stopper piece
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2
- Lots / codes
Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
- Quantity
- 12367 vials
- Company
- Mallinckrodt Hospital Products Inc., Bridgewater, NJ
- Distribution
- USA Nationwide
- Initiated
- August 6, 2026 · Voluntary: Firm initiated
- Classified
- August 26, 2026
- Reported
- September 2, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.